Sepio Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-37,882
Closed -$2.44M 301
2023
Q2
$2.44M Buy
37,882
+1,486
+4% +$99.6K 0.2% 131
2023
Q1
$2.52M Buy
36,396
+31,375
+625% +$2.21M 0.23% 125
2022
Q4
$361K Sell
5,021
-25,860
-84% -$1.95M 0.03% 278
2022
Q3
$2.19M Sell
30,881
-4,789
-13% -$347K 0.22% 127
2022
Q2
$2.75M Buy
+35,670
New +$2.72M 0.28% 111
2021
Q2
Sell
-31,441
Closed -$1.99M 352
2021
Q1
$1.99M Buy
31,441
+13,827
+79% +$860K 0.18% 149
2020
Q4
$1.09M Buy
17,614
+3,906
+28% +$240K 0.09% 225
2020
Q3
$826K Buy
+13,708
New +$825K 0.09% 190
2020
Q2
Sell
-6,676
Closed -$372K 283
2020
Q1
$372K Sell
6,676
-438
-6% -$26.8K 0.05% 203
2019
Q4
$457K Buy
+7,114
New +$407K 0.04% 218

Other funds holding BMY

Sepio Capital's BMY Position: Q3 2023 in Review

Sepio Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 37,882 shares — an estimated $2.44M sold.

Sepio Capital first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $2.75M in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Sepio Capital reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Sepio Capital sold 37,882 Bristol-Myers Squibb shares in Q3 2023, an estimated $2.44M.
  • Sepio Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
  • Sepio Capital's Bristol-Myers Squibb position peaked at $2.75M in Q2 2022.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Sepio Capital's 13F filing for Q3 2023, filed 8 Nov 2023.